INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
MJ
Mahoney Robert JohnEVP Global Operations
ACLSAXCELIS TECHNOLOGIES INC
Open-market sale
SELL$179K
1,155 sh
Jun 2, 2026Jun 3, 2026
Page 716 of 1724
← PrevNext →
traded Jun 2, 2026
+1d
SEC Form 4

Evidence

36
FM
Flatin Jean-Christophe MarieChief Executive Officer
OTLYOatly Group AB
Open-market sale
SELL$17K
1,934 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

35
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Open-market sale
SELL$43K
5,677 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

35
SS
Saint SeanDirector, President & CEO
BBNXBeta Bionics, Inc.
Open-market sale
SELL$213K
16.9K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

35
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$55K
4,378 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

35
RJ
Russell Steven JonChief Medical Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$53K
4,222 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

35
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$84K
6,676 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

35
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Open-market sale
SELL$453K
40.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

35
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$67K
5,329 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

34
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale
SELL$59K
7,679 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

34
KJ
Kim Peter Sung-JipSVP & GM Industrial Business
LFUSLITTELFUSE INC /DE
Open-market sale
SELL$4.91M
10.1K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

32
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Open-market sale
SELL$439K
40.0K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

32
FM
Fruhbeis Todd MichaelDirector
STRRStar Equity Holdings, Inc.
Open-market purchase
BUY$8,204
700 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

31
RC
Rivera CathrynChief Operating Officer
CDZICADIZ INC
Open-market sale
SELL$11K
2,500 sh
May 20, 2026Jun 3, 2026
traded May 20, 2026
+14dSEC Form 4

Evidence

31
NC
Nueno CarlosPresident, International
TDOCTeladoc Health, Inc.
Open-market sale
SELL$47K
6,196 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

28
AA
Alkarmi AshrafDirector, Co-CEO
DBXDROPBOX, INC.
Open-market sale
SELL$632K
22.7K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

28
WJ
Wyrick JasonEVP, Technology
STRZSTARZ ENTERTAINMENT CORP /CN/
Open-market sale
SELL$71K
2,803 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

27
BD
Bender Bradley DChief Risk Officer
TFCTRUIST FINANCIAL CORP
Tax withholding
F$427K
9,115 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

26
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$53K
15.0K sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

23
KM
Klossner MarkEVP and Pres. IPS*
RRXREGAL REXNORD CORP
Grant or award
A$300K
1,484 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

23
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Option exercise
M$290K
40.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

22
HK
Haynes Larry KDirector
CACCAMDEN NATIONAL CORP
Other acquisition or disposition
J—
3,218 sh
May 11, 2026Jun 3, 2026
traded May 11, 2026
+23dSEC Form 4

Evidence

22
HK
Haynes Larry KDirector
CACCAMDEN NATIONAL CORP
Other acquisition or disposition
J—
3,218 sh
May 11, 2026Jun 3, 2026
traded May 11, 2026
+23dSEC Form 4

Evidence

22
HA
Heino Mary AnneDirector, Executive Chair and CEO
LNTHLantheus Holdings, Inc.
Tax withholding
F$119K
1,227 sh
May 14, 2026Jun 3, 2026
traded May 14, 2026
+20dSEC Form 4

Evidence

21
GR
Gaugh David RussellDirector
AMPHAmphastar Pharmaceuticals, Inc.
Grant or award
A—
8,143 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
DS
DeWitt SheilaDirector
ENVBEnveric Biosciences, Inc.
Grant or award
A—
18.5K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
BD
Bender Bradley DChief Risk Officer
TFCTRUIST FINANCIAL CORP
Option exercise
M—
16.1K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
SM
Seidelin MikkelChief Commercial Officer
TNKTEEKAY TANKERS LTD.
Option exercise
M—
2,323 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

21
KR
Kapoor Rohit (RK2)Managing Director, Sinagpore
TNKTEEKAY TANKERS LTD.
Option exercise
M—
697 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

21
EP
Evans Kimberly PetersonGeneral Counsel
BZAIBlaize Holdings, Inc.
Tax withholding
F$48K
27.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
WJ
Watkin Richard JasonPresident, KUBRA
RPAYRepay Holdings Corp
Grant or award
A—
833.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
EP
Evans Kimberly PetersonGeneral Counsel
BZAIBlaize Holdings, Inc.
Option exercise
M—
75.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
GM
Garcia David MichaelSr. VP of Finance
CVCapsoVision, Inc
Grant or award
A—
92.2K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
SM
Seidelin MikkelChief Commercial Officer
TNKTEEKAY TANKERS LTD.
Option exercise
M—
4,906 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

21
DA
deBeers Kimberly A.Director
ACIWACI WORLDWIDE, INC.
Grant or award
A—
5,720 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

21
KJ
Kohl Florian JVP & Pres,Epoxy&International
OLNOLIN Corp
Option exercise
M—
1,250 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
MA
Malik AsthaDirector
WKWORKIVA INC
Grant or award
A—
4,070 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$339K
13.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Grant or award
A—
158.1K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
MR
Maculaitis Victor RayDirector
MVBFMVB FINANCIAL CORP
Option exercise
M—
4,001 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence